Latest News- Allergy Treatment Market: Pharmacological is expected to lead the Therapeutic Area segment during 2025-2029

The Allergy Treatment Market is being driven by Increasing focus on food based allergy treatment

The Allergy Treatment Market is expected to grow at a CAGR of 6.8% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 9939.6 million. The global allergy treatment market is experiencing robust growth, driven by an influx of innovative therapies and generic approvals. Notably, in November 2024, Marksans Pharma Ltd achieved a significant milestone with the US Food and Drug Administration (FDA) granting final approval for their generic version of Loratadine tablets. This approval holds significance as Loratadine is extensively utilized for treating allergic rhinitis, a prevalent condition impacting millions worldwide. The availability of an affordable generic alternative is anticipated to broaden market accessibility and affordability. Simultaneously, in May 2024, Novartis announced promising new data on remibrutinib, a highly selective Bruton tyrosine kinase (BTK) inhibitor, for chronic spontaneous urticaria (CSU). This development underscores the industry's dedication to addressing unmet medical needs and advancing treatment options for allergy sufferers. 

Get more information on Allergy Treatment Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Therapeutic Area
  • Pharmacological
  • Non-pharmacological
• Type
  • Rhinitis
  • Asthma
  • Skin allergy
  • Eye
  • Others
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing focus on food based allergy treatment
• Programs for allergy treatments
• New product launches

However, the market also witnesses some limitations, which are as follows:

• Stringent regulations
• Drug recalls
• Negative health impacts

Benefits of Buying Global Allergy Treatment Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Allergy Treatment Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Allergy Treatment Market encompasses various conditions including atopic dermatitis, hay fever, asthma, and food allergies to latex, peanuts, wheat, soy, eggs, milk, and aeroallergens like grass pollen and mold. Symptoms range from face flushing, teary eyes, and sneezing to more severe reactions such as anaphylaxis, bronchoconstriction, and cardiovascular diseases. Small molecule treatments address vascular permeability, hypersensitivity, and efficacy concerns in allergic diseases like allergic rhinitis and conjunctivitis. Self-medication for allergies includes antihistamines for symptoms like stuffy nose, itching, and vomiting. The World Health Organization emphasizes the importance of effective allergy treatments to improve quality of life and prevent complications like cancer and anaphylaxis.

Market Research Overview

The Allergy Treatment market, a significant segment of the global pharmaceuticals industry, encompasses businesses involved in the research and development (R&D) or production of various allergy treatments, including allergy immunotherapies, natural remedies, and prescription medications. According to Technavio, the global pharmaceuticals market's growth is driven by several factors, including the increasing aging population. By 2050, approximately one-quarter of the US population and Europe's population ratio is projected to be over 60 years old. This demographic shift is expected to fuel the demand for allergy treatments, particularly allergy immunotherapies and tree pollen treatments, as the elderly population is more susceptible to allergies. The Best Allergy Treatment solutions will continue to evolve, with a focus on cost-effective, natural, and innovative approaches to managing allergy symptoms.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/